Physician profile
Arnold Ghitis
NPI 1790860310
$11,052.59
in general payments reported to CMS, 2019-2025
47 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,839 · 2020: $806 · 2021: $828 · 2022: $1,435 · 2023: $2,577 · 2024: $1,781 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,144.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,054.62 | 2019-2025 | Ensite Precision, Jot Dx, Aveir |
| Inari Medical, INC. | $979.18 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $881.02 | 2019-2024 | Xarelto |
| Medtronic, INC. | $848.03 | 2021-2025 | Reveal Linq, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals Lp | $658.84 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.52 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $550.98 | 2020-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $545.08 | 2019-2025 | |
| Boston Scientific Corporation | $513.18 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Amgen INC. | $459.35 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $390.32 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $368.90 | 2019-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $355.14 | 2020-2025 | Lifevest |
| Medtronic Vascular, INC. | $335.45 | 2019-2020 | |
| Heartflow, INC. | $292.25 | 2022-2023 | Ffrct |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $236.68 | 2020-2024 | (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Cardiva Medical, INC. | $218.33 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Osprey Medical INC | $153.47 | 2021 | |
| Merck Sharp & Dohme LLC | $153.09 | 2023-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $146.77 | 2019-2025 | |
| Amarin Pharma, INC. | $113.12 | 2019-2021 | |
| Astellas Pharma US INC | $111.94 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $104.55 | 2025 | Assure Wcd |
| Cvrx, INC. | $89.83 | 2023-2024 | Barostim Neo System |
| Terumo Medical Corporation | $87.14 | 2019-2022 | |
| Cardiovascular Systems INC. | $71.60 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $60.60 | 2024 | Arcalyst |
| Atricure, INC. | $57.74 | 2023-2024 | |
| Esperion Therapeutics, INC. | $55.64 | 2021-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $52.86 | 2019-2020 | |
| Edwards Lifesciences Corporation | $52.24 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $51.79 | 2023 | Inpefa |
| Chiesi USA, INC. | $47.96 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $41.36 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $40.44 | 2019 | |
| Agepha Pharma Fz LLC | $35.69 | 2024 | Lodoco |
| Acist Medical Systems, INC. | $35.44 | 2019 | |
| Gilead Sciences, INC. | $29.70 | 2019 | |
| Altathera Pharmaceuticals LLC | $21.67 | 2025 | Sotalol Hydrochloride |
| Shockwave Medical, INC | $20.88 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $20.56 | 2021 | |
| Novo Nordisk INC | $20.38 | 2023 | Ozempic |
| Medicomp INC | $18.73 | 2019 | |
| Akcea Therapeutics, INC. | $18.36 | 2019 | |
| Preventice Services, LLC | $18.31 | 2021 | |
| Vital Connect, INC | $17.02 | 2023 | Vitalpatch Rtm |
| Tactile Systems Technology INC | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Ghitis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.